CS logo
small CS logo
Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice

Katowice, Poland
University in Katowice
Poniatowskiego 15, 40-055 Katowice

About Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice


The Medical University of Silesia is a university located in Katowice, Poland. The university has 10,218 students and a teaching staff of 1201, including 295 professors. There are five faculties: Medicine, Dentistry, Pharmacy, Public Health, Health Sciences.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice


During the past decade, Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice" #1 collaborator was "PharmaEssentia (Co-Sponsor for USA)" with 1 trials as a collaborator and "PharmaEssentia Corporation (Co-Sponsor for USA)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice


According to Clinical.Site data, the most researched conditions in "Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice" are "Polycythemia Vera" (2 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice" in a lesser frequency.

Clinical Trials Intervention Types at Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice


Most popular intervention types in "Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib" (1 trials), "Carfilzomib" (1 trials), "Hydroxyurea" (1 trials), "Melphalan" (1 trials) and "Peg-P-IFN-alpha-2b (AOP2014)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice


The vast majority of trials in "Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice" are 3 trials for "All" genders.

Clinical Trials Status at Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice


Currently, there are NaN active trials in "Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".